Regarding this, metformin restores AMPK-dependent signaling, leading to inhibition of tumor cell proliferation [22], but further prospective studies exploring its role in STK11-mutant NSCLC are warranted. This evidence concerns the gene STK11 and non-small cell lung carcinoma.